Additionally, PBRM1 deficiency has been associated with increased expression of MHC II molecules and components of the antigen-processing machinery, potentially improving tumor antigen presentation and amplifying CD8+ T cell responses (143, 144). The gene discussed is CD8A; the disease is neoplasm.